体重指数与乳腺皮下脂肪厚度:超声诊断乳腺癌的潜在指标?
该回顾性研究分析1670例患者体重指数(BMI)与临床及超声特征的关系,其中470例用乳腺X线和超声测量乳腺皮下脂肪厚度(SFT),234例分析SFT、BMI与体细胞基因突变的相关性。结果显示BMI≥24 kg/m2者超声恶性特征更多,SFT与肿瘤形状、边界及后方回声特征相关,SFT≥8.6 mm者Ki67水平显著升高,BMI在预测肿瘤增殖和侵袭方面较脂肪厚度更可靠,BMI阈值22 kg/m2较24 kg/m2诊断价值更高。
要点
- BMI≥24 kg/m2的患者表现出更多恶性超声特征。
- 乳腺SFT预测不规则形状、晕环及后方回声衰减的AUC分别为0.605、0.666、0.632,截断值分别为8.65、8.35、8.35 mm。
- 乳腺SFT≥8.6 mm者Ki67水平显著升高(p=.004)。
核心结论
- BMI和乳腺SFT与恶性超声特征相关,两者均有诊断价值,但BMI在预测肿瘤增殖和侵袭方面较脂肪厚度更可靠,BMI阈值22 kg/m2较24 kg/m2诊断价值更高。
研究设计与样本
- 回顾性分析1670例患者BMI与临床及超声特征的关系,其中470例用乳腺X线和超声测量乳腺SFT并评估其与BMI的相关性,234例分析SFT、BMI与体细胞基因突变的相关性。
关键影像表现/征象
- BMI≥24 kg/m2的患者表现出更多恶性超声特征。
- 乳腺SFT在不同形状(p=.025)、边界(p<.001)和后方回声特征(p<.001)的肿瘤间差异显著。
- 乳腺X线测量的SFT与超声测量的SFT相关(r=0.565,p<.001)。
- BMI与乳腺X线测量的SFT(r=0.578,p<.001)及超声测量的SFT(r=0.485,p<.001)均显著相关。
诊断标准与关键数值
- 乳腺SFT预测不规则形状的AUC为0.605,截断值8.65 mm。
- 乳腺SFT预测晕环的AUC为0.666,截断值8.35 mm。
- 乳腺SFT预测后方回声衰减的AUC为0.632,截断值8.35 mm。
- 乳腺SFT≥8.6 mm者Ki67水平显著升高(p=.004)。
- 在脂肪厚度阈值8.60 mm或BMI 24 kg/m2时,体细胞突变频率无差异;BMI≥22 kg/m2时突变频率更高。
临床应用与阅片要点
- BMI和乳腺SFT与恶性超声特征相关,BMI在预测肿瘤增殖和侵袭方面较脂肪厚度更可靠。
- BMI阈值22 kg/m2较24 kg/m2诊断价值更高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Obesity is closely associated with the occurrence and progression of breast cancer. While body mass index (BMI) is widely used to diagnose obesity, it has certain limitations. Subcutaneous fat thickness (SFT) also serves as an indicator of body composition. However, studies on breast SFT are scarce. This study aims to investigate the relationship between BMI, breast SFT, and ultrasound features of breast cancer, as well as their associations with tumor proliferation and invasiveness.
METHODS: This study retrospectively analyzed the relationship between BMI and clinical and ultrasound characteristics in 1670 patients. Among them, breast SFT was measured in 470 patients using mammography and ultrasound, and the correlation between SFT and BMI was assessed. The relationship between ultrasound-measured SFT and pathological as well as ultrasound features was also analyzed. The correlation between breast SFT, BMI, and somatic gene mutations was analyzed in 234 patients.
RESULTS: Patients with BMI ≥24 kg/m2 exhibited more malignant ultrasound features. SFT measured by mammography was correlated with SFT measured by ultrasound (r = 0.565, p < .001). Both BMI and SFT measured via mammography (r = 0.578, p < .001) and ultrasound (r = 0.485, p < .001) showed significant correlations. Breast SFT varied significantly among tumors with different shapes (p = .025), boundaries (p < .001), and posterior echo features (p < .001). The area under the curve (AUC) for breast SFT predicting irregular shape, halo, and posterior shadowing was 0.605, 0.666, and 0.632, respectively, with cutoff values of 8.65, 8.35, and 8.35 mm. Patients with breast SFT ≥8.6 mm demonstrated significantly elevated Ki67 levels (p = .004). No differences in somatic mutation frequencies were found at a threshold of 8.60 mm for fat thickness or at a BMI of 24 kg/m2. However, at BMI ≥22 kg/m2, mutation frequencies were higher.
CONCLUSIONS: BMI and breast SFT are associated with malignant ultrasound features. While both have diagnostic value, BMI is more reliable than fat thickness for predicting cancer proliferation and invasion, with a BMI threshold of 22 kg/m2 offering higher diagnostic value than 24 kg/m2.
引用
- Wang S, Zhou J, Huang Y, et al. BMI and Breast Subcutaneous Fat: Potential Indicators for Ultrasound Diagnosis of Breast Cancer? J Ultrasound Med. 2025. PMID: 41171152. doi:10.1002/jum.70096
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。